1. Home
  2. VS vs XBIO Comparison

VS vs XBIO Comparison

Compare VS & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Versus Systems Inc.

VS

Versus Systems Inc.

N/A

Current Price

$1.25

Market Cap

6.3M

Sector

Technology

ML Signal

N/A

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.65

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VS
XBIO
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VS
XBIO
Price
$1.25
$2.65
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
16.8K
28.6K
Earning Date
11-14-2025
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,179,348.00
$2,858,935.00
Revenue This Year
$3,459.21
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
2281.70
13.30
52 Week Low
$1.15
$1.90
52 Week High
$2.83
$13.93

Technical Indicators

Market Signals
Indicator
VS
XBIO
Relative Strength Index (RSI) 44.21 57.08
Support Level $1.22 $2.51
Resistance Level $1.29 $2.79
Average True Range (ATR) 0.05 0.14
MACD 0.01 0.06
Stochastic Oscillator 55.33 65.44

Price Performance

Historical Comparison
VS
XBIO

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: